Pfizer Upjohn Korea Ltd.
Pfizer Upjohn Korea has conducted various CSR activities such as ¡®Healthy Ageing Campaign¡¯ to improve the life of NCD patients and contribute to the development of local communities in Korea.
Pfizer Upjohn Korea will remain committed to driving business innovation, sustainable growth and industry development to solidify its leadership in the NCD area.
Satellite Symposium
Strategies to Optimize Management of ASCVD
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
Moderator(s): Hyeon-Cheol Gwon
| Opening Speaker: Hyeon-Cheol Gwon |
| If it's All Just LDL -C Reduction, Shouldn¡¯t We Clarify Many Faces of Atorvastatin Lecturer: Bum Joon Kim |
| LEGACY Effect : Navigating Importance of Early Treatment in HTN/DYS Lecturer: Jong-Young Lee |
| Discussion & Closing Speaker: Hyeon-Cheol Gwon |
The Lower, The Better with Evidence
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
| Opening Speaker: Osung Kwon |
| Why is It Imperative to Consider Maximum Tolerable Statin as a First Treatment Option for ASCVD Patients Lecturer: Osung Kwon |
| Individualizing Lipid Management : Selecting the Optimal Drug for the Right Patient Lecturer: Do-Yoon Kang |
| Discussion |
| Closing Speaker: Do-Yoon Kang |
Training Course
Balance of Efficacy and Safety of Intensive Lipid Management
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
| Balance of Efficacy and Safety of Intensive Lipid Management Lecturer: Mahn-Won Park |
Hypertension Management for Intensive BP Control
Organized by CVRF and Supported by Educational Grant from Pfizer Upjohn Korea Ltd.
| Hypertension Management for Intensive BP Control Lecturer: Young Joon Hong |